lats Search Results


95
MedChemExpress lats in 1
Lats In 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lats in 1/product/MedChemExpress
Average 95 stars, based on 1 article reviews
lats in 1 - by Bioz Stars, 2026-02
95/100 stars
  Buy from Supplier

90
Promega crna probe of latency-associated transcripts (lats) labeled with digoxygenin-11-utp
Crna Probe Of Latency Associated Transcripts (Lats) Labeled With Digoxygenin 11 Utp, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crna probe of latency-associated transcripts (lats) labeled with digoxygenin-11-utp/product/Promega
Average 90 stars, based on 1 article reviews
crna probe of latency-associated transcripts (lats) labeled with digoxygenin-11-utp - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Milliken lats method
Lats Method, supplied by Milliken, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lats method/product/Milliken
Average 90 stars, based on 1 article reviews
lats method - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
DuPont de Nemours large tumor suppressor homolog (lats)
Large Tumor Suppressor Homolog (Lats), supplied by DuPont de Nemours, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/large tumor suppressor homolog (lats)/product/DuPont de Nemours
Average 90 stars, based on 1 article reviews
large tumor suppressor homolog (lats) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Cambridge Bioscience lats-in-1
(A-D) Alveolar type 1 cell (AT1) fate differentiation of fdAT2 organoids in 10% human serum-containing medium on 2D culture. Experimental scheme of AT1 differentiation (A), a bright-field image of AT2 organoids upon AT1 differentiation (B), qRT-PCR analysis of AT1 markers AQP5 , CAV1 , and AGER , and an AT2 marker, SFTPC (C), and immunofluorescence imaging with CAV1, E-cadherin, β-actin, and DAPI (nuclei) (D). For RT-qPCT, data were normalised to fdAT2 organoids; mean ± SD, n = 3 independent repeats (*p<0.05, **p<0.01; unpaired t-test (two-tailed)). (E-G) AT1 differentiation of SFTPC -GFP-expressing fdAT2 organoids in a culture medium containing YAP signalling agonist, 10 μM <t>LATS-IN-1,</t> in the absence of Wnt agonists, in 3D organoid culture. Experimental scheme of AT1 differentiation (E), qRT-PCR analysis of AT1 markers AQP5 , CAV1 , and AGER , and an AT2 marker, SFTPC (F), and immunofluorescence imaging with CAV1, AGER, and DAPI (nuclei) (G). For RT-qPCR, data were normalised to fdAT2 organoids; mean ± SD, n=3 independent repeats (*p<0.05, **p<0.01; unpaired t-test (two-tailed)). (H) Explant culture of mouse precision-cut lung slices (PCLS) upon injecting SFTPC -GFP; EF1a -RFP human fdAT2 organoids. Organoids were dissociated and 2 x 10 5 single cells mixed with 100 μl of 50% matrigel and directly injected into each lobe of the lungs. PCLS of 150 μm thickness were cultured for 1 week in 10% fetal bovine serum-containing medium. Three independent lines of fdAT2 organoids were used for the explant culture (16402, 16587, 16392). (I-K) Immunofluorescence images of PCLS showing engrafted and AT1 differentiated human cells. RFP+ cells were monitored by a combination of cell type marker antibodies against SFTPC (I,J), and CAV1 (I) or AGER (J). DAPI, nuclei. Scale bars, 50 μm. Quantitation (K) of AT1-lineage positive human cells in the explants, by measuring the proportion of AT2 (SFTPC) and AT1 markers (CAV1 and AGER) co-localising with RFP (n = 53, SFTPC/CAV1 cells; n = 56, SFTPC/AGER cells; 6 lung slices from 3 biological replicates).
Lats In 1, supplied by Cambridge Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lats-in-1/product/Cambridge Bioscience
Average 90 stars, based on 1 article reviews
lats-in-1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Duodecim Medical Publications long-acting thyroid stimulator (lats)
(A-D) Alveolar type 1 cell (AT1) fate differentiation of fdAT2 organoids in 10% human serum-containing medium on 2D culture. Experimental scheme of AT1 differentiation (A), a bright-field image of AT2 organoids upon AT1 differentiation (B), qRT-PCR analysis of AT1 markers AQP5 , CAV1 , and AGER , and an AT2 marker, SFTPC (C), and immunofluorescence imaging with CAV1, E-cadherin, β-actin, and DAPI (nuclei) (D). For RT-qPCT, data were normalised to fdAT2 organoids; mean ± SD, n = 3 independent repeats (*p<0.05, **p<0.01; unpaired t-test (two-tailed)). (E-G) AT1 differentiation of SFTPC -GFP-expressing fdAT2 organoids in a culture medium containing YAP signalling agonist, 10 μM <t>LATS-IN-1,</t> in the absence of Wnt agonists, in 3D organoid culture. Experimental scheme of AT1 differentiation (E), qRT-PCR analysis of AT1 markers AQP5 , CAV1 , and AGER , and an AT2 marker, SFTPC (F), and immunofluorescence imaging with CAV1, AGER, and DAPI (nuclei) (G). For RT-qPCR, data were normalised to fdAT2 organoids; mean ± SD, n=3 independent repeats (*p<0.05, **p<0.01; unpaired t-test (two-tailed)). (H) Explant culture of mouse precision-cut lung slices (PCLS) upon injecting SFTPC -GFP; EF1a -RFP human fdAT2 organoids. Organoids were dissociated and 2 x 10 5 single cells mixed with 100 μl of 50% matrigel and directly injected into each lobe of the lungs. PCLS of 150 μm thickness were cultured for 1 week in 10% fetal bovine serum-containing medium. Three independent lines of fdAT2 organoids were used for the explant culture (16402, 16587, 16392). (I-K) Immunofluorescence images of PCLS showing engrafted and AT1 differentiated human cells. RFP+ cells were monitored by a combination of cell type marker antibodies against SFTPC (I,J), and CAV1 (I) or AGER (J). DAPI, nuclei. Scale bars, 50 μm. Quantitation (K) of AT1-lineage positive human cells in the explants, by measuring the proportion of AT2 (SFTPC) and AT1 markers (CAV1 and AGER) co-localising with RFP (n = 53, SFTPC/CAV1 cells; n = 56, SFTPC/AGER cells; 6 lung slices from 3 biological replicates).
Long Acting Thyroid Stimulator (Lats), supplied by Duodecim Medical Publications, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/long-acting thyroid stimulator (lats)/product/Duodecim Medical Publications
Average 90 stars, based on 1 article reviews
long-acting thyroid stimulator (lats) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Tokyo Chemical Industry lats respondents
Demographic Characteristics and Smoking Behavior Reported by Participants in Three Tobacco-Related Surveys, Louisiana, 2010 and 2013 <xref ref-type= a " width="250" height="auto" />
Lats Respondents, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lats respondents/product/Tokyo Chemical Industry
Average 90 stars, based on 1 article reviews
lats respondents - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Promega crna probe for lats labeled with digoxigenin-11– utp
Demographic Characteristics and Smoking Behavior Reported by Participants in Three Tobacco-Related Surveys, Louisiana, 2010 and 2013 <xref ref-type= a " width="250" height="auto" />
Crna Probe For Lats Labeled With Digoxigenin 11– Utp, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crna probe for lats labeled with digoxigenin-11– utp/product/Promega
Average 90 stars, based on 1 article reviews
crna probe for lats labeled with digoxigenin-11– utp - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ABclonal Biotechnology anti-lats2 a16249
Demographic Characteristics and Smoking Behavior Reported by Participants in Three Tobacco-Related Surveys, Louisiana, 2010 and 2013 <xref ref-type= a " width="250" height="auto" />
Anti Lats2 A16249, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-lats2 a16249/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
anti-lats2 a16249 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
ABclonal Biotechnology p-lats (catalog no. ap0880)
Demographic Characteristics and Smoking Behavior Reported by Participants in Three Tobacco-Related Surveys, Louisiana, 2010 and 2013 <xref ref-type= a " width="250" height="auto" />
P Lats (Catalog No. Ap0880), supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p-lats (catalog no. ap0880)/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
p-lats (catalog no. ap0880) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Genechem lentivirus vectors sh-lats b
Sequences of <t> lentivirus </t> Sh‐RNA
Lentivirus Vectors Sh Lats B, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lentivirus vectors sh-lats b/product/Genechem
Average 90 stars, based on 1 article reviews
lentivirus vectors sh-lats b - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
BioResource International Inc ndr/lats-family protein kinase genes
Sequences of <t> lentivirus </t> Sh‐RNA
Ndr/Lats Family Protein Kinase Genes, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ndr/lats-family protein kinase genes/product/BioResource International Inc
Average 90 stars, based on 1 article reviews
ndr/lats-family protein kinase genes - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


(A-D) Alveolar type 1 cell (AT1) fate differentiation of fdAT2 organoids in 10% human serum-containing medium on 2D culture. Experimental scheme of AT1 differentiation (A), a bright-field image of AT2 organoids upon AT1 differentiation (B), qRT-PCR analysis of AT1 markers AQP5 , CAV1 , and AGER , and an AT2 marker, SFTPC (C), and immunofluorescence imaging with CAV1, E-cadherin, β-actin, and DAPI (nuclei) (D). For RT-qPCT, data were normalised to fdAT2 organoids; mean ± SD, n = 3 independent repeats (*p<0.05, **p<0.01; unpaired t-test (two-tailed)). (E-G) AT1 differentiation of SFTPC -GFP-expressing fdAT2 organoids in a culture medium containing YAP signalling agonist, 10 μM LATS-IN-1, in the absence of Wnt agonists, in 3D organoid culture. Experimental scheme of AT1 differentiation (E), qRT-PCR analysis of AT1 markers AQP5 , CAV1 , and AGER , and an AT2 marker, SFTPC (F), and immunofluorescence imaging with CAV1, AGER, and DAPI (nuclei) (G). For RT-qPCR, data were normalised to fdAT2 organoids; mean ± SD, n=3 independent repeats (*p<0.05, **p<0.01; unpaired t-test (two-tailed)). (H) Explant culture of mouse precision-cut lung slices (PCLS) upon injecting SFTPC -GFP; EF1a -RFP human fdAT2 organoids. Organoids were dissociated and 2 x 10 5 single cells mixed with 100 μl of 50% matrigel and directly injected into each lobe of the lungs. PCLS of 150 μm thickness were cultured for 1 week in 10% fetal bovine serum-containing medium. Three independent lines of fdAT2 organoids were used for the explant culture (16402, 16587, 16392). (I-K) Immunofluorescence images of PCLS showing engrafted and AT1 differentiated human cells. RFP+ cells were monitored by a combination of cell type marker antibodies against SFTPC (I,J), and CAV1 (I) or AGER (J). DAPI, nuclei. Scale bars, 50 μm. Quantitation (K) of AT1-lineage positive human cells in the explants, by measuring the proportion of AT2 (SFTPC) and AT1 markers (CAV1 and AGER) co-localising with RFP (n = 53, SFTPC/CAV1 cells; n = 56, SFTPC/AGER cells; 6 lung slices from 3 biological replicates).

Journal: bioRxiv

Article Title: A novel human fetal lung-derived alveolar organoid model reveals mechanisms of surfactant protein C maturation relevant to interstitial lung disease

doi: 10.1101/2023.08.30.555522

Figure Lengend Snippet: (A-D) Alveolar type 1 cell (AT1) fate differentiation of fdAT2 organoids in 10% human serum-containing medium on 2D culture. Experimental scheme of AT1 differentiation (A), a bright-field image of AT2 organoids upon AT1 differentiation (B), qRT-PCR analysis of AT1 markers AQP5 , CAV1 , and AGER , and an AT2 marker, SFTPC (C), and immunofluorescence imaging with CAV1, E-cadherin, β-actin, and DAPI (nuclei) (D). For RT-qPCT, data were normalised to fdAT2 organoids; mean ± SD, n = 3 independent repeats (*p<0.05, **p<0.01; unpaired t-test (two-tailed)). (E-G) AT1 differentiation of SFTPC -GFP-expressing fdAT2 organoids in a culture medium containing YAP signalling agonist, 10 μM LATS-IN-1, in the absence of Wnt agonists, in 3D organoid culture. Experimental scheme of AT1 differentiation (E), qRT-PCR analysis of AT1 markers AQP5 , CAV1 , and AGER , and an AT2 marker, SFTPC (F), and immunofluorescence imaging with CAV1, AGER, and DAPI (nuclei) (G). For RT-qPCR, data were normalised to fdAT2 organoids; mean ± SD, n=3 independent repeats (*p<0.05, **p<0.01; unpaired t-test (two-tailed)). (H) Explant culture of mouse precision-cut lung slices (PCLS) upon injecting SFTPC -GFP; EF1a -RFP human fdAT2 organoids. Organoids were dissociated and 2 x 10 5 single cells mixed with 100 μl of 50% matrigel and directly injected into each lobe of the lungs. PCLS of 150 μm thickness were cultured for 1 week in 10% fetal bovine serum-containing medium. Three independent lines of fdAT2 organoids were used for the explant culture (16402, 16587, 16392). (I-K) Immunofluorescence images of PCLS showing engrafted and AT1 differentiated human cells. RFP+ cells were monitored by a combination of cell type marker antibodies against SFTPC (I,J), and CAV1 (I) or AGER (J). DAPI, nuclei. Scale bars, 50 μm. Quantitation (K) of AT1-lineage positive human cells in the explants, by measuring the proportion of AT2 (SFTPC) and AT1 markers (CAV1 and AGER) co-localising with RFP (n = 53, SFTPC/CAV1 cells; n = 56, SFTPC/AGER cells; 6 lung slices from 3 biological replicates).

Article Snippet: For in vitro AT1 differentiation, AT2 organoids were dissociated into single cells and 1 x 10 cells were replated on matrigel-coated 12-well dishes and cultured either 1) in an AT1-promoting medium containing 10% human serum for 2 weeks or 2) in medium containing the LATS1 and 2 inhibitor LATS-IN-1 (10 mM, Cambridge Bioscience, CAY36623) and in the absence of CHIR99021 for a week.

Techniques: Quantitative RT-PCR, Marker, Immunofluorescence, Imaging, Two Tailed Test, Expressing, Injection, Cell Culture, Quantitation Assay

Demographic Characteristics and Smoking Behavior Reported by Participants in Three Tobacco-Related Surveys, Louisiana, 2010 and 2013 <xref ref-type= a " width="100%" height="100%">

Journal: Preventing Chronic Disease

Article Title: Differences in Treating Tobacco Use Across National, State, and Public Hospital System Surveys

doi: 10.5888/pcd15.170575

Figure Lengend Snippet: Demographic Characteristics and Smoking Behavior Reported by Participants in Three Tobacco-Related Surveys, Louisiana, 2010 and 2013 a

Article Snippet: The percentage of 2013 LATS white respondents increased to 57% from 52% in 2010, while the percentage of 2013 TCI white participants decreased from 52% to 48%.

Techniques:

Smoking Cessation Assistance Using 5 A’s (Ask, Advise, Assess, Assist, Arrange) Tobacco Cessation Intervention Reported by Respondents to 3 Surveys, Louisiana, 2010 and 2013 <xref ref-type= a " width="100%" height="100%">

Journal: Preventing Chronic Disease

Article Title: Differences in Treating Tobacco Use Across National, State, and Public Hospital System Surveys

doi: 10.5888/pcd15.170575

Figure Lengend Snippet: Smoking Cessation Assistance Using 5 A’s (Ask, Advise, Assess, Assist, Arrange) Tobacco Cessation Intervention Reported by Respondents to 3 Surveys, Louisiana, 2010 and 2013 a

Article Snippet: The percentage of 2013 LATS white respondents increased to 57% from 52% in 2010, while the percentage of 2013 TCI white participants decreased from 52% to 48%.

Techniques:

Adjusted <xref ref-type= a Odds Ratios of Having Received Any Component of the 5 A's Tobacco Cessation Intervention and a Quit Attempt, Respondents to 3 Surveys, Louisiana, 2010 and 2013" width="100%" height="100%">

Journal: Preventing Chronic Disease

Article Title: Differences in Treating Tobacco Use Across National, State, and Public Hospital System Surveys

doi: 10.5888/pcd15.170575

Figure Lengend Snippet: Adjusted a Odds Ratios of Having Received Any Component of the 5 A's Tobacco Cessation Intervention and a Quit Attempt, Respondents to 3 Surveys, Louisiana, 2010 and 2013

Article Snippet: The percentage of 2013 LATS white respondents increased to 57% from 52% in 2010, while the percentage of 2013 TCI white participants decreased from 52% to 48%.

Techniques:

Sequences of  lentivirus  Sh‐RNA

Journal: Cell Proliferation

Article Title: AMOT 130 linking F‐actin to YAP is involved in intervertebral disc degeneration

doi: 10.1111/cpr.12492

Figure Lengend Snippet: Sequences of lentivirus Sh‐RNA

Article Snippet: Lentivirus vectors contain the LATS1 and LATS2 knockdown (Sh‐LATS A and Sh‐LATS B) or a negative control sequence (Sh‐Control) (GeneChem, Shanghai, China).

Techniques: Sequencing, Control